Centene Corporation (NYSE: CNC) reported third-quarter 2019 adjusted earnings of $0.96 per share versus $0.95 per share expected.
Total revenues grew by 17% to $19 billion versus $18.43 billion expected. This was driven by the growth in the Health Insurance Marketplace business, expansions and new programs in many states, and its recent acquisitions in Spain.
As of September 30, 2019, managed care membership rose by 6% year-over-year to 15.3 million.
Looking ahead into 2019, the company now expects total revenues in the range of $73.6 billion to $74.2 billion, versus consensus estimates of $74.37 billion.
For 2019, GAAP earnings are predicted to be in the $3.04 to $3.21 per share range and adjusted earnings are anticipated to be between $4.29 and $4.49 per share. The market analysts expect earnings of $4.41 per share for the full year.
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated
The healthcare sector is going through a phase of consolidation, creating fresh opportunities for emerging companies in a market that is slowly recovering from the pandemic. Several pharmaceuticals firms have
Shares of American Airlines Group (NASDAQ: AAL) have gained 42% since the beginning of this year and 50% over the past 12 months. Despite this, there is a mixed sentiment